Erlotinib combination with a mitochondria-targeted ubiquinone effectively suppresses pancreatic cancer cell survival
P. Y. Leung(Medical College of Wisconsin), Jong‐In Park(Johns Hopkins University), Pui–Kei Wu(Medical College of Wisconsin), Wenjing Chen(Medical College of Wisconsin), Anissa N Sari(Medical College of Wisconsin), Poojitha Sitaram(Medical College of Wisconsin), Susan Tsai(The Ohio State University Wexner Medical Center)
Cited by 6
Related Papers
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
|BMC Cancer|2018|391
Plasma extracellular RNA profiles in healthy and cancer patients
|Scientific Reports|2016|294
Circulating giant macrophages as a potential biomarker of solid tumors
|Proceedings of the National Academy of Sciences|2014|281
Microwave Ablation for Hepatic Malignancies
|Annals of Surgery|2013|254